No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs555339855 |
chr2:53920894-53920895 |
Strong transcription Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs575277086 |
chr2:53920929-53920930 |
Strong transcription Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs544605441 |
chr2:53920930-53920931 |
Strong transcription Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs7563054 |
chr2:53920931-53920932 |
Strong transcription Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
5 |
rs578067224 |
chr2:53920936-53920937 |
Strong transcription Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs545643001 |
chr2:53920938-53920939 |
Strong transcription Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs554900752 |
chr2:53920939-53920940 |
Strong transcription Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs559530738 |
chr2:53920945-53920946 |
Strong transcription Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs370907983 |
chr2:53920946-53920947 |
Strong transcription Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs192039591 |
chr2:53920970-53920971 |
Strong transcription Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs542189565 |
chr2:53920981-53920982 |
Strong transcription Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs561657007 |
chr2:53920985-53920986 |
Strong transcription Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs371065314 |
chr2:53920986-53920987 |
Strong transcription Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs374158367 |
chr2:53920988-53920989 |
Strong transcription Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs530479061 |
chr2:53920998-53920999 |
Strong transcription Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs550554402 |
chr2:53921000-53921001 |
Strong transcription Weak transcription Enhancers Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs376224250 |
chr2:53921013-53921014 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs149703788 |
chr2:53921023-53921024 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs370438766 |
chr2:53921047-53921048 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs145452596 |
chr2:53921053-53921054 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs11553661 |
chr2:53921056-53921057 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs202150949 |
chr2:53921057-53921058 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs201926371 |
chr2:53921063-53921064 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs150481865 |
chr2:53921093-53921094 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs367649992 |
chr2:53921133-53921134 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs138349062 |
chr2:53921138-53921139 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs3731971 |
chr2:53921151-53921152 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs535737252 |
chr2:53921178-53921179 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs371491315 |
chr2:53921200-53921201 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs569209581 |
chr2:53921230-53921231 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs184641040 |
chr2:53921231-53921232 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs3731970 |
chr2:53921270-53921271 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
33 |
rs578023921 |
chr2:53921272-53921273 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs534332344 |
chr2:53921290-53921291 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs553203760 |
chr2:53921293-53921294 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs75885371 |
chr2:53921294-53921295 |
Weak transcription Strong transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|